EUCTR2004-002420-18-GB进行中（未招募）不适用
A prospective, non-randomised, non-controlled, open label, multicentre phase II study: PTK 787/ZK222584 in patients with advanced neuroendocrine tumours - PTK878/ZK 222584 in patients with advanced NET
CHARITE Universitätsmedizin Berlin Campus Virchow-Klinikum0 个研究点目标入组 35 人开始时间: 2005年3月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) Measurable histologically and immunohistologically confirmed neuroendocrine tumour NET
- •2) Tumour proliferation as measured by Ki67 15%
- •3) Age > 18 years
- •4) WHO performance status 0-2
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) High grade NET (Ki67 > 15%)
- •2) Chemotherapy 4 weeks prior to study entry
- •3) Embolisation or Chemoembolisation less than 3 months prior to study entry
- •4) Not recovered from surgery and no surgery within 2 weeks
- •5) Embolisation in the previous 3 months
- •6) Investigational drugs within 4 weeks
- •7) Pregnant or breast feeding
- •8) Adults in reproductive potential not using an effective method (ie barrier method) of birth control
- •9) Other contraindication are listed in section 3.2.3 of the protocol
研究者
相似试验
进行中（未招募）
1 期
A prospective, non-randomized, non-controlled, open label, multicenter phase II Study: PTK 787/ ZK222584 in patients with advanced neuroendocrine tumors. - not availableEUCTR2004-002420-18-DEProf. B. Wiedenmann, Klinik für Gastroenterologie, Charité, Campus Virchow54
招募中
不适用
Impact of mental health and stress on Physical Recovery of Patients after Total Joint ReplacementCTRI/2022/03/041238Self funded Mrs Shilpi Singh
尚未招募
4 期
A prospective, randomized, controlled, non-inferiority trial comparing RF- energy and cryoenergy in pulmonary vein isolation in patients with persistent atrial fibrillatioI48.1Persistent atrial fibrillationDRKS00010840Medizinische Klinik IVStädtisches Klinikum Karlsruhe340
已完成
不适用
on-randomized, prospective, non-controlled study of changes of lipid parameters after introduction of evolocumab in patients with heterozygous familial hypercholesterolemia under LDL-apheresis therapy.Homozygous familial hypercholesterolemiaJPRN-UMIN000022603Kanazawa University Hospital2
进行中（未招募）
4 期
A comparative study to evaluate the efficacy and safety of Troxipide (100 mg) and Rabeprazole (20 mg) alone and in combination in patients of Acid peptic disorders.CTRI/2013/09/003944Government Medical College Hospital100